Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,295 | 291 | 99.1% |
| Education | $38.78 | 4 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $935.17 | 73 | $0 (2024) |
| Lilly USA, LLC | $506.66 | 31 | $0 (2024) |
| PFIZER INC. | $301.57 | 20 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $270.98 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $230.61 | 15 | $0 (2024) |
| ABBVIE INC. | $220.34 | 13 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $183.26 | 25 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $173.84 | 14 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $116.48 | 5 | $0 (2024) |
| Amgen Inc. | $111.00 | 7 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $835.98 | 44 | Novo Nordisk Inc ($227.37) |
| 2023 | $315.48 | 17 | Lilly USA, LLC ($57.22) |
| 2022 | $574.65 | 30 | Lilly USA, LLC ($119.25) |
| 2021 | $550.45 | 34 | Novo Nordisk Inc ($102.18) |
| 2020 | $118.30 | 8 | Genentech USA, Inc. ($18.89) |
| 2019 | $721.79 | 53 | Novo Nordisk Inc ($165.43) |
| 2018 | $621.38 | 47 | Novo Nordisk Inc ($134.92) |
| 2017 | $595.91 | 62 | Novo Nordisk Inc ($154.53) |
All Payment Transactions
295 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Obesity | ||||||
| 12/04/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: PAIN | ||||||
| 11/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.77 | General |
| Category: Obesity | ||||||
| 11/12/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $31.07 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Diabetes | ||||||
| 10/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: Diabetes | ||||||
| 10/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.88 | General |
| Category: Obesity | ||||||
| 09/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.04 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 08/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Obesity | ||||||
| 07/31/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: Diabetes | ||||||
| 07/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $21.66 | General |
| Category: Endocrinology | ||||||
| 07/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: DIABETES | ||||||
| 06/27/2024 | Baxter Healthcare | Hillrom - Cardiac Ambulatory Monitor (Device) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Cardiac Arrhythmia Monitoring | ||||||
| 06/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Obesity | ||||||
| 06/26/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: WOMENS HEALTH | ||||||
| 06/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 354 | 669 | $127,834 | $50,070 |
| 2022 | 12 | 511 | 1,010 | $162,495 | $64,137 |
| 2021 | 13 | 797 | 1,463 | $187,000 | $68,845 |
| 2020 | 12 | 521 | 1,076 | $167,483 | $53,823 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 106 | 290 | $69,600 | $22,071 | 31.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 85 | 85 | $20,400 | $10,381 | 50.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 125 | $19,375 | $7,252 | 37.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 24 | 97 | $9,976 | $4,135 | 41.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 13 | 13 | $5,148 | $3,658 | 71.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 19 | 20 | $1,580 | $1,435 | 90.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 25 | 26 | $1,300 | $758.42 | 58.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $455.00 | $379.21 | 83.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 125 | 319 | $76,560 | $25,040 | 32.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 92 | 92 | $22,080 | $11,551 | 52.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 86 | 160 | $24,800 | $9,330 | 37.6% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 43 | 186 | $19,130 | $8,503 | 44.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $4,752 | $3,342 | 70.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 38 | 38 | $3,002 | $2,605 | 86.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 21 | 37 | $3,145 | $1,300 | 41.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 44 | 44 | $2,200 | $1,234 | 56.1% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 12 | 16 | $3,856 | $678.62 | 17.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 14 | $490.00 | $394.25 | 80.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 12 | 12 | $720.00 | $98.42 | 13.7% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 13 | 80 | $1,760 | $60.76 | 3.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 131 | 385 | $92,400 | $33,348 | 36.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 77 | 77 | $18,480 | $10,054 | 54.4% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time per calendar month | Office | 2021 | 45 | 226 | $23,244 | $6,868 | 29.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 71 | 108 | $16,740 | $6,586 | 39.3% |
| 0012A | Adm sarscov2 100mcg/0.5ml2nd | Office | 2021 | 88 | 88 | $9,296 | $3,348 | 36.0% |
About Dr. William Hebda, M.D
Dr. William Hebda, M.D is a Family Medicine healthcare provider based in Clayton, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1417051681.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Hebda, M.D has received a total of $4,334 in payments from pharmaceutical and medical device companies, with $835.98 received in 2024. These payments were reported across 295 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($4,295).
As a Medicare-enrolled provider, Hebda has provided services to 2,183 Medicare beneficiaries, totaling 4,218 services with total Medicare billing of $236,875. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Clayton, NC
- Active Since 09/11/2006
- Last Updated 06/04/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1417051681
Products in Payments
- Ozempic (Drug) $236.82
- Wegovy (Drug) $202.14
- Saxenda (Drug) $188.41
- JARDIANCE (Drug) $181.54
- VRAYLAR (Drug) $175.78
- MOUNJARO (Drug) $166.20
- TRULICITY (Drug) $156.69
- REXULTI (Drug) $147.78
- JANUVIA (Drug) $113.68
- BYDUREON (Drug) $103.03
- QELBREE (Drug) $96.51
- FARXIGA (Drug) $94.95
- Belviq (Drug) $92.79
- TRADJENTA (Drug) $85.65
- Rybelsus (Drug) $84.40
- Stendra (Drug) $82.20
- VYVANSE (Drug) $74.31
- CHANTIX (Drug) $73.76
- Trintellix (Drug) $63.90
- NURTEC ODT (Drug) $59.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Clayton
Bhavna Vaidya-Tank, Md, MD
Family Medicine — Payments: $11,671
Joan Meehan, Do, DO
Family Medicine — Payments: $11,035
Brian Pratt, Md, MD
Family Medicine — Payments: $9,650
Dr. Steven Kaplan, M.d, M.D
Family Medicine — Payments: $8,325
Dr. Aaron Huizenga, D.o, D.O
Family Medicine — Payments: $4,229
Dr. Jana Tomsky, M.d, M.D
Family Medicine — Payments: $4,224